Oseltamivir compounding in the hospital pharmacy during the (H1N1) influenza pandemic

Marin, Márcia Lúcia de Mário; Oliveira, Bruno Barbosa do Carmo; Cipriano, Sonia Lucena; Suslik, Carlos Alberto; Faintuch, Joel.
Clinics ; 65(11): 1081-1086, 2010. ilus, graf, tab
Artículo en Inglés | LILACS | ID: lil-571420

Documentos relacionados

  1. Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics.
  2. Oseltamivir prescribing in pharmacy-benefits database, United States, 2004-2005.
  3. H1N1: a Mexican perspective.
  4. Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico.
  5. Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs.
  6. Dosing regimen optimisation for oseltamivir in immunocompromised paediatric patients with influenza: Extrapolation of efficacy.
  7. Patient-oriented pandemic influenza research.
  8. Tamiflu still prudent for pandemic influenza, PHAC maintains.
  9. Inhaled Zanamivir vs Oral Oseltamivir to Prevent Influenza-related Hospitalization or Death: A Nationwide Population-based Quasi-experimental Study.
  10. Frequency and distribution of H1N1 influenza A viruses with oseltamivir-resistant mutations worldwide before and after the 2009 pandemic.